ValoreQ4, 24Q1, 25Q2, 25Q3, 25Q4, 25TTMSpese di vendita, generali e amministrative2.12 B2.3 B2.08 B2.04 B2.23 B8.65 BRicerca e sviluppo358 M405 M407 M410 M401 M1.62 BReddito operativo581 M837 M1.11 B1.14 B1.8 B4.89 BProventi non operativi, Totale-53 M-73 M-97 M-106 M508 M232 MOneri finanziari, al netto degli interessi capitalizzati104 M137 M159 M157 M129 M582 MProventi non operativi, esclusi gli oneri finanziari-157 M-210 M-256 M-263 M379 M-350 MEntrate/uscite straordinarie——————Utile al lordo delle imposte528 M764 M1.02 B1.03 B1.71 B4.51 BQuota di utile——————Imposte-18 M110 M132 M170 M856 M1.27 BInteressi di minoranza——————Altri proventi/oneri al netto delle imposte——————Utile netto al lordo delle attività cessate546 M654 M884 M859 M849 M3.25 BAttività cessate——————Utile netto546 M654 M884 M859 M849 M3.25 BRegolazione della diluizione——————Dividendi privilegiati——————Utile netto diluito attribuibile agli azionisti ordinari546 M654 M884 M859 M849 M3.25 BUtile base per azione (EPS base)1.431.712.322.252.218.49Utile diluito per azione (EPS diluito)1.411.692.292.222.28.4Numero medio di azioni ordinarie in circolazione381 M381.7 M382.2 M382.4 M382.2 M1.53 BAzioni diluite in circolazione385.6 M386.4 M386.4 M386.7 M386.5 M1.55 BEBITDA927 M1.2 B1.5 B1.54 B2.22 B6.46 BEBIT581 M837 M1.11 B1.14 B1.8 B4.89 BCosto del fatturato2.26 B2.12 B2.18 B2.21 B2.54 B9.05 BAltri costi del venduto——————Ammortamento e svalutazione (liquidità)346 M361 M389 M404 M416 M1.57 B
Stryker Corporation
Stryker Corporation is an American multinational medical technologies corporation based in Portage, Michigan, United States. The company's products are used for medical surgery and neurotechnology, which include surgical equipment, patient and caregiver safety technologies, endoscopy systems, and patient handling, emergency medical equipment, and intensive care disposable products, as well as neurosurgical, neurovascular and oral and maxillofacial surgery implant products; and orthopedic surgery, which includes implants used in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. Stryker's products are sold in over 75 countries and are used by 150 million patients annually. In 2024, 75% of the company's revenues came from the United States.
The company is ranked 195th on the Fortune 500 and 331st on the Forbes Global 2000.